Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system
Crossref DOI link: https://doi.org/10.1038/s41598-023-37944-x
Published Online: 2023-07-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xiao, Yao
Chen, Yiqian
Huang, Yan
Xiao, Yuan
Text and Data Mining valid from 2023-07-05
Version of Record valid from 2023-07-05
Article History
Received: 11 March 2023
Accepted: 30 June 2023
First Online: 5 July 2023
Competing interests
: The authors declare no competing interests.